ANI Pharmaceuticals: Nikhil Lalwani plans $400K share sale

ANI PHARMACEUTICALS, INC (symbol ANIP) is named as the issuer in a Rule 144 notice filed for the account of Nikhil S. Lalwani.

Rhea-AI Filing Summary

ANI PHARMACEUTICALS, INC (symbol ANIP) is named as the issuer in a Rule 144 notice filed for the account of Nikhil S. Lalwani. The notice covers a proposed sale of 5,400 shares of ANI common stock through Morgan Stanley Smith Barney LLC, with an associated value of $400,518.00 based on NASDAQ pricing as of 08/25/2026. The 5,400 shares are reported as having been acquired on 02/28/2026 as an RSA from the issuer. The filing does not indicate additional sales of this class during the preceding three months.

Key Figures

Shares proposed to be sold: 5,400 shares Proposed aggregate sale value: $400,518.00 Class-level share figure: 22,959,000 shares +2 more

5 metrics

Shares proposed to be sold 5,400 shares Common stock in Rule 144 notice through Morgan Stanley Smith Barney LLC

Proposed aggregate sale value $400,518.00 Value shown for the 5,400 shares of common stock

Class-level share figure 22,959,000 shares Figure appearing in the securities information table for the same class

Acquisition date of shares 02/28/2026 Date the 5,400 shares were acquired as RSA from issuer

Pricing date reference 08/25/2026 Date listed in the securities information table with NASDAQ

Key Terms

Rule 144, RSA, Executive Financial Services

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSA financial

"Common | 02/28/2026 | RSA | Issuer | | | 5400 | 02/28/2026 | N/A"

Executive Financial Services financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ANIP disclose?

It discloses that Nikhil S. Lalwani has filed a Rule 144 notice for a proposed sale of 5,400 shares of ANI PHARMACEUTICALS, INC common stock through Morgan Stanley Smith Barney LLC, with an associated value of $400,518.00 based on NASDAQ pricing on 08/25/2026.

How many ANIP shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 5,400 shares of ANI PHARMACEUTICALS, INC common stock, with an associated value of $400,518.00 as shown in the securities information table.

When were the ANIP shares in this Form 144 acquired and in what form?

The 5,400 shares were acquired on 02/28/2026 as an RSA (restricted stock award) from the issuer, ANI PHARMACEUTICALS, INC, according to the securities-to-be-sold section.

What trading venue and date reference are associated with the ANIP Form 144 sale?

The securities information table references NASDAQ and the date 08/25/2026 in connection with the proposed sale of 5,400 ANIP common shares and the related value of $400,518.00.

Does the ANIP Form 144 list recent sales of this security by the filer?

The section for Securities Sold During The Past 3 Months does not list any entries, indicating no additional sales of this class are reported there for the preceding three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:42 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:42 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001822629
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI PHARMACEUTICALS, INC
SEC File Number	001-31812
Address of Issuer	104 Carnegie Center Drive, Suite 300 Princeton NEW JERSEY 08540
Phone	(609)759-1810
Name of Person for Whose Account the Securities are To Be Sold	NIKHIL LALWANI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5400	400518.00	22959000	08/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2026	RSA	Issuer			5400	02/28/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nikhil S Lalwani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)